세계의 유전학적 검사 시장 보고서(2025년)

Hereditary testing, also known as genetic testing for inherited conditions, involves analyzing an individual's DNA to detect genetic mutations or variations inherited from their parents. These tests help evaluate the risk of developing or passing on inherited diseases, assist in diagnosing genetic disorders, and support personalized treatment or preventive care decisions.

The primary types of hereditary testing include predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic testing, and others. Predictive testing is used to determine the likelihood that an individual will develop a particular disease or condition in the future, before symptoms arise. Sample types for these tests include blood, saliva, tissue, buccal swabs, and urine. The technologies employed range from next-generation sequencing (NGS), polymerase chain reaction (PCR), Sanger sequencing, microarray technology, to whole genome sequencing (WGS). These tests are applied in various fields such as oncology, cardiovascular diseases, neurological disorders, metabolic disorders, and more, and are utilized by a wide range of end users including hospitals, diagnostic labs, research institutions, pharmaceutical companies, patients, and consumers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The hereditary testing market research report is one of a series of new reports from The Business Research Company that provides hereditary testing market statistics, including hereditary testing industry global market size, regional shares, competitors with a hereditary testing market share, detailed hereditary testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary testing industry. The hereditary testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary testing market size has grown strongly in recent years. It will grow from $6.05 billion in 2024 to $6.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be credited to increasing parental age, broader use in cancer risk assessment, heightened demand for early diagnosis and prevention, a rising burden of rare and chronic diseases, improved access to genetic counseling services, and greater adoption of hereditary testing in reproductive health.

The hereditary testing market size is expected to see strong growth in the next few years. It will grow to $9.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The anticipated growth in the forecast period can be attributed to expanding collaborations between public and private genomic initiatives, rising demand for non-invasive prenatal testing (NIPT), an increasing variety of genetic testing panels and kits, greater use in population-wide screening programs, and a stronger focus on preventive and precision public health. Key trends during this period include advancements in next-generation sequencing (NGS), technological innovations in NIPT, progress in bioinformatics platforms, improvements in point-of-care genetic testing devices, and developments in multi-gene panel testing.

The rising prevalence of genetic disorders is expected to drive the growth of the hereditary testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's deoxyribonucleic acid (DNA), inherited from one or both parents or occurring spontaneously. The increase in genetic disorders is partly due to higher parental age, which raises the chances of passing genetic mutations to offspring. Hereditary testing aids patients with genetic disorders by enabling early diagnosis, guiding personalized treatments, and assisting family planning decisions through the identification of inherited mutations. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity, reported that the number of registered cystic fibrosis patients increased to 11,318 in 2023, up from 11,148 in 2022. Thus, the growing prevalence of genetic disorders is fueling the hereditary testing market.

Key players in the hereditary testing market are focusing on technological advancements in genetic test kits to improve accuracy, shorten turnaround times, and expand the detection of a wider range of genetic mutations. Genetic test kits are diagnostic tools designed to analyze an individual's DNA to identify mutations or variations linked to inherited diseases or risk factors. For instance, in July 2023, Devyser Diagnostics AB, a Sweden-based biotech company specializing in DNA diagnostic kits for hereditary diseases, launched two new targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP allows comprehensive analysis of PMS2 (addressing challenges from its pseudogene PMS2CL) along with nine other key genes associated with hereditary colorectal cancer syndromes. Devyser BRCA PALB2 provides a streamlined single-tube solution for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples, designed to support efficient lab workflows with user-friendly sequencing and dedicated software for confident detection of hereditary cancer risks.

In May 2025, GeneDx LLC, a US-based biotechnology firm specializing in genetic testing, acquired Fabric Genomics for an undisclosed sum. This acquisition aims to enhance GeneDx's genomic interpretation capabilities by integrating Fabric Genomics' AI-powered platform, thereby strengthening its hereditary disease diagnostic offerings and enabling faster, more scalable genetic analysis. Fabric Genomics is a US-based computational genomics company providing hereditary testing solutions.

Major players in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

North America was the largest region in the hereditary testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hereditary testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hereditary testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hereditary testing market includes revenues earned by entities through services such as genetic screening, pharmacogenetic testing, and presymptomatic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Predictive Testing; Carrier Testing; Prenatal Testing; Newborn Screening; Diagnostic Testing; Other Test Types
• 2) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Buccal Swabs; Urine Samples
• 3) By Technology Used: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Sanger Sequencing; Microarray Technology; Whole Genome Sequencing (WGS)
• 4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Metabolic Disorders; Other Applications
• 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Patients And Consumers
• Subsegments:
• 1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing; Lynch Syndrome Testing; Familial Hypercholesterolemia Testing; Huntington's Disease Testing; Cardiomyopathy Genetic Testing
• 2) By Carrier Testing: Cystic Fibrosis Carrier Screening; Tay-Sachs Carrier Screening; Spinal Muscular Atrophy (SMA) Carrier Screening; Thalassemia Carrier Screening; Sickle Cell Carrier Testing
• 3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT); Chorionic Villus Sampling (CVS); Amniocentesis; Expanded Carrier Screening (Prenatal Context); Cell-Free Fetal Deoxyribonucleic Acid Testing
• 4) By Newborn Screening: Phenylketonuria (PKU) Screening; Congenital Hypothyroidism Screening; Cystic Fibrosis Screening; Sickle Cell Disease Screening; Hearing Loss and Metabolic Disorder Panels
• 5) By Diagnostic Testing: Rare Disease Genetic Testing; Inherited Cancer Diagnostic Testing; Cardiogenetic Diagnostic Panels; Neurogenetic Disorder Testing; Monogenic Disease Panels
• 6) By Other Test Types: Pharmacogenomics Testing; Preimplantation Genetic Diagnosis (PGD); Whole Exome Sequencing (WES); Whole Genome Sequencing (WGS); Mitochondrial Deoxyribonucleic Acid Testing
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; CooperSurgical Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc; Invitae Corporation; GeneDx LLC; Twist Bioscience Corporation; Color Health Inc.; MedGenome Inc; SOPHiA GENETICS SA; Gene By Gene Ltd.; Dante Labs Inc.; 23mofang Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hereditary Testing Market Characteristics

3. Hereditary Testing Market Trends And Strategies

4. Hereditary Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hereditary Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hereditary Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hereditary Testing Market Growth Rate Analysis
• 5.4. Global Hereditary Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hereditary Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hereditary Testing Total Addressable Market (TAM)

6. Hereditary Testing Market Segmentation

• 6.1. Global Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Testing
• Carrier Testing
• Prenatal Testing
• Newborn Screening
• Diagnostic Testing
• Other Test Types
• 6.2. Global Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Samples
• Saliva Samples
• Tissue Samples
• Buccal Swabs
• Urine Samples
• 6.3. Global Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Sanger Sequencing
• Microarray Technology
• Whole Genome Sequencing (WGS)
• 6.4. Global Hereditary Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Metabolic Disorders
• Other Applications
• 6.5. Global Hereditary Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Pharmaceutical Companies
• Patients And Consumers
• 6.6. Global Hereditary Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer 1 (BRCA1) And Breast Cancer 2 (BRCA2) Gene Mutation Testing
• Lynch Syndrome Testing
• Familial Hypercholesterolemia Testing
• Huntington's Disease Testing
• Cardiomyopathy Genetic Testing
• 6.7. Global Hereditary Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cystic Fibrosis Carrier Screening
• Tay-Sachs Carrier Screening
• Spinal Muscular Atrophy (SMA) Carrier Screening
• Thalassemia Carrier Screening
• Sickle Cell Carrier Testing
• 6.8. Global Hereditary Testing Market, Sub-Segmentation Of Prenatal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Chorionic Villus Sampling (CVS)
• Amniocentesis
• Expanded Carrier Screening (Prenatal Context)
• Cell-Free Fetal Deoxyribonucleic Acid Testing
• 6.9. Global Hereditary Testing Market, Sub-Segmentation Of Newborn Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenylketonuria (PKU) Screening
• Congenital Hypothyroidism Screening
• Cystic Fibrosis Screening
• Sickle Cell Disease Screening
• Hearing Loss And Metabolic Disorder Panels
• 6.10. Global Hereditary Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rare Disease Genetic Testing
• Inherited Cancer Diagnostic Testing
• Cardiogenetic Diagnostic Panels
• Neurogenetic Disorder Testing
• Monogenic Disease Panels
• 6.11. Global Hereditary Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacogenomics Testing
• Preimplantation Genetic Diagnosis (PGD)
• Whole Exome Sequencing (WES)
• Whole Genome Sequencing (WGS)
• Mitochondrial Deoxyribonucleic Acid Testing

7. Hereditary Testing Market Regional And Country Analysis

• 7.1. Global Hereditary Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hereditary Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hereditary Testing Market

• 8.1. Asia-Pacific Hereditary Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hereditary Testing Market

• 9.1. China Hereditary Testing Market Overview
• 9.2. China Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hereditary Testing Market

• 10.1. India Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hereditary Testing Market

• 11.1. Japan Hereditary Testing Market Overview
• 11.2. Japan Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hereditary Testing Market

• 12.1. Australia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hereditary Testing Market

• 13.1. Indonesia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hereditary Testing Market

• 14.1. South Korea Hereditary Testing Market Overview
• 14.2. South Korea Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hereditary Testing Market

• 15.1. Western Europe Hereditary Testing Market Overview
• 15.2. Western Europe Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hereditary Testing Market

• 16.1. UK Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hereditary Testing Market

• 17.1. Germany Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hereditary Testing Market

• 18.1. France Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hereditary Testing Market

• 19.1. Italy Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hereditary Testing Market

• 20.1. Spain Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hereditary Testing Market

• 21.1. Eastern Europe Hereditary Testing Market Overview
• 21.2. Eastern Europe Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hereditary Testing Market

• 22.1. Russia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hereditary Testing Market

• 23.1. North America Hereditary Testing Market Overview
• 23.2. North America Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hereditary Testing Market

• 24.1. USA Hereditary Testing Market Overview
• 24.2. USA Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hereditary Testing Market

• 25.1. Canada Hereditary Testing Market Overview
• 25.2. Canada Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hereditary Testing Market

• 26.1. South America Hereditary Testing Market Overview
• 26.2. South America Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hereditary Testing Market

• 27.1. Brazil Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hereditary Testing Market

• 28.1. Middle East Hereditary Testing Market Overview
• 28.2. Middle East Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hereditary Testing Market

• 29.1. Africa Hereditary Testing Market Overview
• 29.2. Africa Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hereditary Testing Market Competitive Landscape And Company Profiles

• 30.1. Hereditary Testing Market Competitive Landscape
• 30.2. Hereditary Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hereditary Testing Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. CooperSurgical Inc.
• 31.3. QIAGEN N.V
• 31.4. Natera Inc.
• 31.5. Myriad Genetics Inc.
• 31.6. Fulgent Genetics Inc
• 31.7. Invitae Corporation
• 31.8. GeneDx LLC
• 31.9. Twist Bioscience Corporation
• 31.10. Color Health Inc.
• 31.11. MedGenome Inc
• 31.12. SOPHiA GENETICS SA
• 31.13. Gene By Gene Ltd.
• 31.14. Dante Labs Inc.
• 31.15. 23mofang Co. Ltd.

32. Global Hereditary Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hereditary Testing Market

34. Recent Developments In The Hereditary Testing Market

35. Hereditary Testing Market High Potential Countries, Segments and Strategies

• 35.1 Hereditary Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hereditary Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hereditary Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer